Alpha-2 blocker
Alpha-2 blockers (or α2 blockers) are a subset of the alpha blocker class of drugs and are antagonists to the α2 adrenergic receptor. They are mainly used in research, having found limited clinical application in human medicine. They are extensively used in veterinary medicine to reverse the effects of alpha-2 agonist drugs used as sedatives, like xylazine, medetomidine and dexmedetomidine. Alpha-2 blockers increase noradrenaline release.
Uses
Yohimbine, historically used as an aphrodisiac, is sometimes used in veterinary medicine (although now largely replaced by atipamezole) for reversing the effects of α2s such as medetomidine that are used as sedatives during surgery.[1]
The tetracyclic antidepressants mianserin and mirtazapine are α2 blockers, although their efficacy as antidepressants may come from their activity at other receptor sites.Script error: No such module "Unsubst".
Mechanistically, α2 blockers increase adrenergic, dopaminergic and serotonergic neurotransmitters and induce insulin secretion, decreasing blood sugar levels.Script error: No such module "Unsubst".
Withdrawal from α2 blockers can be difficult or dangerous as the global downregulation of neurotransmitters may cause symptoms of depression and other neurological problems, and increased blood sugar levels together with decreased insulin sensitivity can cause diabetes.Script error: No such module "Unsubst". Moreover, reduced microcirculation together with adrenaline supersensitivity in organs such as liver can occur.Script error: No such module "Unsubst".
Examples
Examples include atipamezole,[2] efaroxan, idazoxan,[3] yohimbine, and rauwolscine, phentolamine.
References
<templatestyles src="Reflist/styles.css" />
Script error: No such module "Check for unknown parameters".